$EFX

Baird Cuts Equifax Price Target to $193 From $232, Maintains Outperform Rating

Baird reduced its price target for Equifax from $232 to $193, citing updated valuation metrics. The firm maintained an 'Outperform' rating. Equifax's stock is currently trading at $140.31, down 35.93% year-to-date.

Original reporting
Published Oct 2, 2026, 2:52 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 2, 2026, 4:08 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$EFX
Bearish
high confidence
Mentioned
$EFX
Relevance
6/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$EFXBearishMed
01

Why it matters

The target cut reflects concerns about earnings outlook or competitive pressures.

02

Market read

Analyst downgrade may trigger short-term sell pressure in EFX and could affect peer stocks.

03

What to watch

Potential upcoming regulatory changes or macro data could offset the target cut.

Relevance 6/10Novelty 6/10Timing: today

Background

Equifax is a major consumer credit reporting agency; analyst price target changes often influence its stock.

Company-level read

Ticker impact

$EFXBearishHigh confidence
Context

Baird lowered Equifax's price target to $193 from $232, indicating a bearish outlook.

Expected impact

likely pressure as the market prices in the lower target

Evidence & confidence

Target reduction is a direct catalyst that can prompt short-term sell pressure.

Market effects

May weigh on other credit reporting firms as valuation expectations tighten.

Limited to US equity markets; no broader regional effect.

Low global relevance; primarily impacts US investors.

Counterpoint

Some investors may see the lower target as a buying opportunity if they believe the cut is overly pessimistic.

Key entities

  • Baird

    Equity research firm issuing the price target revision.

  • Equifax

    Consumer credit reporting company (ticker EFX).

Related articles

$EFXMed

How that 20-point Equifax error may have cost you thousands

Equifax agreed to a $100M settlement over a coding error that allegedly caused 20-point credit score inaccuracies for 4M consumers in 2022. The error could have affected mortgage, auto loan, and credit card rates. Affected consumers may receive $95-$280, with claims due by Dec. 28, 2026. Equifax denies wrongdoing.

$EFXMed

What to do if you qualify for the Equifax error settlement

Equifax agreed to a $100M settlement over alleged misreporting of credit scores for 4M Americans between March and April 2022, according to the law firm Gibbs Mura. The error allegedly lowered scores by over 20 points, affecting loan approvals and interest rates. Equifax denies wrongdoing but will pay impacted individuals, pending final approval in 2027. Affected consumers can claim compensation by 2026.

$EFXLow

You could get a payment from Equifax's $100M settlement

Equifax agreed to a $100M settlement for a 2022 class-action lawsuit alleging incorrect credit score reporting. The error affected about 4M Americans, potentially impacting loan approvals. Payments of $95-$280 are estimated for eligible claimants, with a final hearing set for 2027.

$EFXMed

Equifax and TransUnion shares fall on mortgage credit report rule change

Equifax (EFX) and TransUnion (TRU) shares fell 4% and 7% respectively after reports that FHFA may ease mortgage credit report rules. TransUnion trades near its 52-week low, down 27% YTD. The change could impact revenue and EBITDA for both firms. TransUnion reported strong Q2 earnings, with mixed analyst reactions to its price target. The company also faces credit scoring landscape shifts.

$EFXMed

Equifax (EFX) Stock Trades Up, Here Is Why

Equifax (EFX) shares rose 2.7% after Barclays cut its price target to $155 from $200, citing negative sentiment in the business services sector. Barclays maintained an Equal Weight rating. The stock later cooled to $143.41, up 2.6%. Equifax faces regulatory pressure from the FHFA's mortgage pricing grid changes and TransUnion's pricing strategy. The stock is down 33% YTD and 40.2% from its 52-week high.